FIELD: pharmacology.
SUBSTANCE: group of inventions relates to a new drug suitable for the treatment of inflammatory periodontal diseases, and a pharmaceutical composition based on it. The proposed agent is 2-ethyl-6-methyl-3-hydroxypyridinium-2-(3-benzoylphenyl)-propanoate. A pharmaceutical composition is proposed for the treatment of inflammatory periodontal diseases in the form of a gel, which contains the above drug dissolved in alcohols — ethyl alcohol and propylene glycol, and a hydrophilic base from a cellulose derivative and water.
EFFECT: proposed agent and composition have pronounced antioxidant and anti-inflammatory properties, stimulate the reparative processes of periodontal tissues, inhibit the destructive processes of tissues of the periodontal complex, which allows them to be used as effective pathogenetic agents for inflammatory periodontal diseases.
4 cl, 13 dwg, 5 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
DRUG WITH ANTIHYPOXIC, ANTIAMNESTIC AND NEUROPROTECTIVE ACTIVITY | 2020 |
|
RU2750418C1 |
AGENT WITH PANCREAS AND HEPATOPROTECTIVE ACTIVITY FOR PARENTERAL ADMINISTRATION | 2017 |
|
RU2662324C1 |
METHOD OF CORRECTING BACTERIAL PURULENT MENINGITIS BY 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM 2,6-DICHLOROPHENYL(AMINO)PHENYL ETHANOATE UNDER EXPERIMENTAL CONDITIONS | 2019 |
|
RU2724883C1 |
NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
L-ENANTYMER OF 2-ETHYL-6-METHYL-3-HYDROXYPIRIDINIUM HYDROXYBUTANDIOATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2017 |
|
RU2663836C1 |
COMPLEX SALTS OF ACIDUM ACEXAMICUM, STIMULATING REGENERATION OF BONE TISSUE, ACCELERATING PROCESSES OF REPARATIVE OSTEOGENESIS, STIMULATING MINERALIZATION OF BONE TISSUE IN OSTEOPOROSIS | 2018 |
|
RU2668966C1 |
NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
METHOD FOR CORRECTING OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM HYDROXYBUTANEDIOATE IN EXPERIMENT | 2021 |
|
RU2775439C1 |
Authors
Dates
2023-04-04—Published
2022-03-31—Filed